The South America Radiotherapy Market is expected to reach a market size of more than 0.41 Billion by 2031.
The South America radiotherapy market is a developing regional market characterised by significant infrastructure deficits, rising cancer incidence, and substantial government investment in healthcare modernisation. The region encompasses diverse markets with Brazil and Argentina representing the largest economies and healthcare systems, while Colombia, Chile, and Peru face critical equipment shortages relative to population needs. The Pan American Health Organization (PAHO) has called on governments in Latin America and the Caribbean to prioritise access to essential cancer medicines, supplies, and equipment for cancer treatment. The International Atomic Energy Agency (IAEA) and PAHO continue to support capacity building across the region, with a particular focus on expanding radiotherapy access in underserved areas. According to the research report, "South America Radiotherapy Market Outlook, 2031," published by Bonafide Research, the South America Radiotherapy Market is expected to reach a market size of more than 0.41 Billion by 2031. Brazil represents the largest market in the region, supported by its large population and substantial public healthcare infrastructure through the Sistema Único de Saúde (SUS). Argentina contributes a significant market with ongoing investment in modernisation, including major paediatric radiotherapy infrastructure. Colombia, Chile, and Peru represent emerging growth opportunities with significant infrastructure deficits and government commitments to expansion. External Beam Radiotherapy (EBRT) represents the largest therapy segment across South America, driven by the installed base of linear accelerators. Systemic radiotherapy is the fastest-growing therapy segment, fueled by the emergence of novel radiopharmaceuticals. Radiotherapy systems and equipment hold the largest offering segment share, while software and services represent the fastest-growing segment. Breast cancer is the largest application segment, while central nervous system and brain cancers are the fastest-growing. Hospitals and integrated cancer centres dominate end-use spending, with academic and research institutions growing fastest.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Therapy Type | External Beam Radiotherapy (EBRT) | |
| Internal / Brachytherapy | ||
| Systemic Radiotherapy | ||
| By Offering | Radiotherapy Systems/Equipment | |
| Software & Services | ||
| By Technology | Image-Guided Radiotherapy | |
| Intensity-Modulated Radiotherapy | ||
| Stereotactic Radiosurgery | ||
| Proton Beam Therapy | ||
| 3D-Conformal Radiotherapy | ||
| Volumetric Modulated Arc Therapy | ||
| Other Technology | ||
| By Application | Breast Cancer | |
| Prostate Cancer | ||
| Lung Cancer | ||
| Head & Neck Cancer | ||
| Central Nervous System / Brain | ||
| Gastro-intestinal | ||
| Other Applications | ||
| By End User | Hospitals & Integrated Cancer Centers | |
| Standalone Radiotherapy Centers | ||
| Academic/Research Institutions | ||
| Other Healthcare Facilities | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
External Beam Radiotherapy (EBRT) is the largest therapy segment because the installed base of linear accelerators and the clinical dominance of advanced techniques including IMRT, IGRT, and SBRT make it the modality of choice for a broad spectrum of malignancies across South America. External Beam Radiotherapy (EBRT) represents the largest therapy segment in the South America radiotherapy market, driven by the installed base of linear accelerators and the clinical dominance of advanced techniques. EBRT is the modality of choice for a broad spectrum of malignancies due to its effectiveness, non-invasiveness, and well-established evidence base. In Brazil, the government has delivered linear accelerators, with each accelerator capable of treating hundreds of new patients per year. Colombia has LINACs, inclusive of CyberKnife and Gamma Knife machines. The segment continues to benefit from technological enhancements, including advanced stereotactic delivery systems. Major equipment suppliers including Elekta and Varian Medical Systems dominate the EBRT segment with their LINAC platforms. Brazil's plans to acquire additional linear accelerators demonstrate sustained investment in this segment. Systemic Radiotherapy is the fastest-growing therapy segment because the emergence of novel radiopharmaceuticals and targeted radionuclide therapies is creating new treatment options for specific malignancies across the region. Systemic Radiotherapy represents the fastest-growing therapy segment in the South America radiotherapy market, fueled by the emergence of novel radiopharmaceuticals and targeted radionuclide therapies for treating metastatic prostate cancer, neuroendocrine tumors, and certain lymphomas. The IAEA and PAHO are supporting the development of nuclear medicine capabilities across the region. Colombia's Ministry of Health has proposed regulatory frameworks for pharmaceuticals, including radiopharmaceuticals. This segment is a focal point for innovation and represents a significant area for future market expansion. Radiotherapy Systems/Equipment is the largest offering segment because high capital costs, continuous technological innovation, and government investment programmes drive substantial investment in treatment delivery systems across South America. Radiotherapy Systems/Equipment represents the largest offering segment in the South America radiotherapy market, driven by the high capital cost of advanced treatment delivery systems. This includes linear accelerators, brachytherapy afterloaders, and stereotactic radiosurgery platforms. Growth in this segment is sustained by government investment programmes and the replacement of aging equipment across the installed base. Brazil's federal government has invested in linear accelerators delivered in 2025, with plans to acquire additional equipment. Argentina's Hospital Garrahan investment includes a paediatric linear accelerator. Major suppliers include Elekta and Varian Medical Systems. Software & Services is the fastest-growing offering segment because the increasing digitalisation of radiation oncology, workforce shortages, and the need for comprehensive lifecycle management are driving demand for advanced software solutions and maintenance services. Software & Services represents the fastest-growing offering segment in the South America radiotherapy market, reflecting the increasing digitalisation of radiation oncology. The software component includes advanced treatment planning systems and AI-powered contouring and dose optimisation tools. The services component encompasses installation, comprehensive maintenance, clinical training, and physics support. The trend toward outsourcing maintenance and support services, driven by workforce constraints and the growing complexity of equipment, is a key driver for this segment. Healthcare providers seek to manage operational costs while ensuring high uptime and compliance, creating sustained demand for comprehensive service agreements. Proton Beam Therapy is the fastest-growing technology segment because the expansion of proton therapy infrastructure, supported by clinical evidence and investment, is creating new opportunities for this advanced modality. Proton Beam Therapy represents the fastest-growing technology segment in the South America radiotherapy market, reflecting the emerging interest in advanced particle therapy. While proton therapy remains limited in the region, with Brazil and other countries exploring proton therapy centres, the segment represents significant growth potential. The IAEA and PAHO are supporting capacity building for advanced radiotherapy technologies across the region. Breast Cancer is the largest application segment because high incidence rates and the well-established role of radiotherapy in both breast-conserving therapy and post-mastectomy settings sustain steady demand for treatment equipment and planning software across South America. Breast Cancer represents the largest application segment in the South America radiotherapy market, driven by the high incidence of breast cancer and the well-established role of radiotherapy in treatment. In Brazil, breast cancer is one of the most frequently diagnosed cancers. In Colombia, breast cancer is among the most common cancers. In Ecuador, breast cancer is among the most detected cancers. The expansion of screening programmes has led to earlier detection, further driving demand for radiotherapy as a component of multidisciplinary care. Central Nervous System / Brain is the fastest-growing application because the use of stereotactic radiosurgery for brain metastases and the adoption of advanced radiotherapy techniques are driving investment in specialised equipment and software. Central Nervous System / Brain represents the fastest-growing application in the South America radiotherapy market, driven by the use of stereotactic radiosurgery for brain metastases and the adoption of advanced radiotherapy techniques. Colombia has Gamma Knife machines for stereotactic radiosurgery. Argentina's Hospital Garrahan has acquired a paediatric linear accelerator with unique radiocure characteristics for the region. The technological complexity and precision requirements of CNS radiotherapy drive investment in specialised equipment and software. Hospitals & Integrated Cancer Centres are the largest end-user segment because these institutions provide comprehensive cancer care and possess the infrastructure and clinical expertise to invest in advanced radiotherapy technologies. Hospitals & Integrated Cancer Centres represent the largest end-user segment in the South America radiotherapy market, as these institutions provide comprehensive cancer care and possess the infrastructure and clinical expertise to invest in radiotherapy technologies. In Brazil, radiotherapy services are primarily delivered through public hospitals and integrated cancer centres operating within the SUS framework. The government has delivered linear accelerators to hospitals across all states. In Argentina, the Hospital Garrahan, a leading paediatric hospital, is receiving major investment in radiotherapy infrastructure. Academic/Research Institutions are the fastest-growing end-user segment because their central role in advancing the field through clinical trials, technology validation, and workforce training drives high adoption rates of innovative technologies. Academic/Research Institutions represent the fastest-growing end-user segment in the South America radiotherapy market, reflecting their central role in advancing the field. They conduct clinical trials, develop and test new technologies, validate emerging treatment protocols, and train the next generation of radiation oncologists, medical physicists, and therapists. Their high adoption rate of innovative technologies makes them a key driver of market growth and a bellwether for broader clinical adoption.
to Download this information in a PDF
Brazil dominates the South America radiotherapy market because of its large population, substantial government investment in healthcare infrastructure, and the scale of its public health system, with the federal government delivering linear accelerators in 2025 and planning additional equipment. Brazil represents the largest radiotherapy market in South America, supported by its position as the region's most populous country and its substantial healthcare infrastructure through the Sistema Único de Saúde (SUS). INCA estimates that the 2026–2028 triennium will record approximately 781,000 new cancer cases per year, an 11% growth. The federal government has delivered linear accelerators in 2025, with all states now having radiotherapy centres. The Ministry of Health plans to acquire additional linear accelerators. The government has also announced additional annual funding for radiotherapy. However, Brazil faces challenges: the SBRT's RT 2030 report identified a structural deficit, with equipment units against a minimum need. An estimated proportion of the existing LINAC base was installed before 2015 and is due for retirement. Brazil is expected to remain the dominant national market and a key driver of the South America radiotherapy market. Argentina represents a significant market with ongoing government investment in modernisation, including a major paediatric radiotherapy infrastructure project at the Hospital Garrahan. Argentina represents a significant radiotherapy market with a well-established healthcare system and substantial government investment in modernisation. The government has announced a significant investment for the Hospital Garrahan, including the acquisition of a paediatric linear accelerator, the first of its kind in paediatric hospitals in Latin America. The Elekta Evo linear accelerator is part of this investment. Argentina's radiotherapy market is experiencing growth as the country's healthcare sector invests in advanced cancer treatment technologies and facilities. The country continues to modernise its radiotherapy infrastructure, supported by government commitment to improving cancer care. Colombia represents a significant growth opportunity because the country faces a substantial infrastructure deficit, with multiple states lacking any LINACs and a current deficit of equipment required to meet IAEA standards. Colombia represents a significant growth opportunity in the South America radiotherapy market, driven by substantial infrastructure deficits and government commitment to expansion. Colombia has LINACs, but these are unevenly distributed: multiple states do not have any LINACs. Colombia maintains a ratio of LINACs per million inhabitants, falling short of IAEA guidelines. The country faces a ratio of cancer patients per LINAC, surpassing the IAEA's advised ratio, requiring additional equipment to align with international standards. The Ministry of Health has strengthened radiological safety standards and updated licensing requirements. This infrastructure deficit creates substantial demand for equipment procurement, installation services, and comprehensive maintenance contracts. Other South American countries including Peru, Ecuador, and Venezuela provide additional growth opportunities as healthcare infrastructure expands and cancer incidence rises across the region. Peru represents a growing market, with cancer leading mortality in the country. Each year, a significant number of new cases are detected. Ecuador reports thousands of new cancer cases annually. SOLCA Manabí has incorporated the first Versa HD linear accelerator in the country. Venezuela estimates care for tens of thousands of oncology patients through a national network of specialised centres, including radiotherapy units, with additional units planned. These countries represent growth opportunities as healthcare infrastructure expands and cancer incidence rises.
to Download this information in a PDF

We are friendly and approachable, give us a call.